Cargando…

Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study

BACKGROUND: Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobu...

Descripción completa

Detalles Bibliográficos
Autores principales: La, David, Czarnecki, Chris, El-Gabalawy, Hani, Kumar, Anand, Meyers, Adrienne F. A., Bastien, Nathalie, Simonsen, J. Neil, Plummer, Francis A., Luo, Ma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247251/
https://www.ncbi.nlm.nih.gov/pubmed/22216211
http://dx.doi.org/10.1371/journal.pone.0029200
_version_ 1782220065756676096
author La, David
Czarnecki, Chris
El-Gabalawy, Hani
Kumar, Anand
Meyers, Adrienne F. A.
Bastien, Nathalie
Simonsen, J. Neil
Plummer, Francis A.
Luo, Ma
author_facet La, David
Czarnecki, Chris
El-Gabalawy, Hani
Kumar, Anand
Meyers, Adrienne F. A.
Bastien, Nathalie
Simonsen, J. Neil
Plummer, Francis A.
Luo, Ma
author_sort La, David
collection PubMed
description BACKGROUND: Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobulin-like receptors (KIR) and HLA class I ligand interactions. To study factors involved in NK cell dysfunction in overactive immune responses to H1N1 infection, KIR3DL1/S1 and KIR2DL2/L3 allotypes and cognate HLA ligands of H1N1/09 intensive-care unit (ICU) patients were determined. METHODOLOGY AND FINDINGS: KIR3DL1/S1, KIR2DL2/L3, and HLA -B and -C of 51 H1N1/09 ICU patients and 105 H1N1-negative subjects (St. Theresa Point, Manitoba) were characterized. We detected an increase of 3DL1 ligand-negative pairs (3DL1/S1(+) Bw6(+) Bw4(−)), and a lack of 2DL1 HLA-C2 ligands, among ICU patients. They were also significantly enriched for 2DL2/L3 ligand-positive pairs (P<0.001, Pc<0.001; Odds Ratio:6.3158, CI95%:2.481–16.078). Relative to St. Theresa aboriginals (STh) and Venezuelan Amerindians (VA), allotypes enriched among aboriginal ICU patients (Ab) were: 2DL3 (Ab>VA, P = 0.024, Pc = 0.047; Odds Ratio:2.563, CI95%:1.109–5.923), 3DL1*00101 (Ab>VA, P<0.001, Pc<0.001), 3DL1*01502 (Ab>STh, P = 0.034, Pc = 0.268), and 3DL1*029 (Ab>STh, P  = 0.039, Pc = 0.301). Aboriginal patients ligand-positive for 3DL1/S1 and 2DL1 had the lowest probabilities of death (R(d)) (R(d) = 28%), compared to patients that were 3DL1/S1 ligand-negative (R(d) = 52%) or carried 3DL1*029 (R(d) = 52%). Relative to Caucasoids (CA), two allotypes were enriched among non-aboriginal ICU patients (NAb): 3DL1*00401 (NAb>CA, P<0.001, Pc<0.001) and 3DL1*01502 (CA<NAb, P = 0.012, Pc = 0.156). Non-aboriginal patients with ligands for all three KIRs (3DL1/S1, 2DL2/L3, and 2DL1) had the lowest probabilities of death (R(d) = 36%), compared to subjects with 3DL1*01502 (R(d) = 48%) and/or 3DL1*00401 (R(d) = 58%). CONCLUSIONS: Specific KIR3DL1/S1 allotypes, 3DL1/S1 and 2DL1 ligand-negative pairs, and 2DL2/L3 ligand-positive pairs were enriched among ICU patients. This suggests a possible association with NK cell dysfunction in patients with overactive immune responses to H1N1/09, leading to severe disease.
format Online
Article
Text
id pubmed-3247251
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32472512012-01-03 Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study La, David Czarnecki, Chris El-Gabalawy, Hani Kumar, Anand Meyers, Adrienne F. A. Bastien, Nathalie Simonsen, J. Neil Plummer, Francis A. Luo, Ma PLoS One Research Article BACKGROUND: Infection by the pandemic influenza A (H1N1/09) virus resulted in significant pathology among specific ethnic groups worldwide. Natural Killer (NK) cells are important in early innate immune responses to viral infections. Activation of NK cells, in part, depend on killer-cell immunoglobulin-like receptors (KIR) and HLA class I ligand interactions. To study factors involved in NK cell dysfunction in overactive immune responses to H1N1 infection, KIR3DL1/S1 and KIR2DL2/L3 allotypes and cognate HLA ligands of H1N1/09 intensive-care unit (ICU) patients were determined. METHODOLOGY AND FINDINGS: KIR3DL1/S1, KIR2DL2/L3, and HLA -B and -C of 51 H1N1/09 ICU patients and 105 H1N1-negative subjects (St. Theresa Point, Manitoba) were characterized. We detected an increase of 3DL1 ligand-negative pairs (3DL1/S1(+) Bw6(+) Bw4(−)), and a lack of 2DL1 HLA-C2 ligands, among ICU patients. They were also significantly enriched for 2DL2/L3 ligand-positive pairs (P<0.001, Pc<0.001; Odds Ratio:6.3158, CI95%:2.481–16.078). Relative to St. Theresa aboriginals (STh) and Venezuelan Amerindians (VA), allotypes enriched among aboriginal ICU patients (Ab) were: 2DL3 (Ab>VA, P = 0.024, Pc = 0.047; Odds Ratio:2.563, CI95%:1.109–5.923), 3DL1*00101 (Ab>VA, P<0.001, Pc<0.001), 3DL1*01502 (Ab>STh, P = 0.034, Pc = 0.268), and 3DL1*029 (Ab>STh, P  = 0.039, Pc = 0.301). Aboriginal patients ligand-positive for 3DL1/S1 and 2DL1 had the lowest probabilities of death (R(d)) (R(d) = 28%), compared to patients that were 3DL1/S1 ligand-negative (R(d) = 52%) or carried 3DL1*029 (R(d) = 52%). Relative to Caucasoids (CA), two allotypes were enriched among non-aboriginal ICU patients (NAb): 3DL1*00401 (NAb>CA, P<0.001, Pc<0.001) and 3DL1*01502 (CA<NAb, P = 0.012, Pc = 0.156). Non-aboriginal patients with ligands for all three KIRs (3DL1/S1, 2DL2/L3, and 2DL1) had the lowest probabilities of death (R(d) = 36%), compared to subjects with 3DL1*01502 (R(d) = 48%) and/or 3DL1*00401 (R(d) = 58%). CONCLUSIONS: Specific KIR3DL1/S1 allotypes, 3DL1/S1 and 2DL1 ligand-negative pairs, and 2DL2/L3 ligand-positive pairs were enriched among ICU patients. This suggests a possible association with NK cell dysfunction in patients with overactive immune responses to H1N1/09, leading to severe disease. Public Library of Science 2011-12-28 /pmc/articles/PMC3247251/ /pubmed/22216211 http://dx.doi.org/10.1371/journal.pone.0029200 Text en La et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
La, David
Czarnecki, Chris
El-Gabalawy, Hani
Kumar, Anand
Meyers, Adrienne F. A.
Bastien, Nathalie
Simonsen, J. Neil
Plummer, Francis A.
Luo, Ma
Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title_full Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title_fullStr Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title_full_unstemmed Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title_short Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
title_sort enrichment of variations in kir3dl1/s1 and kir2dl2/l3 among h1n1/09 icu patients: an exploratory study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247251/
https://www.ncbi.nlm.nih.gov/pubmed/22216211
http://dx.doi.org/10.1371/journal.pone.0029200
work_keys_str_mv AT ladavid enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT czarneckichris enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT elgabalawyhani enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT kumaranand enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT meyersadriennefa enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT bastiennathalie enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT simonsenjneil enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT plummerfrancisa enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy
AT luoma enrichmentofvariationsinkir3dl1s1andkir2dl2l3amongh1n109icupatientsanexploratorystudy